Better in Medical Technology

IBM and EU Partners Create a Better Way to Fight AIDS Virus

EuResist HIV Treatment Prediction Tool Wins Top Honors in Computerworld Honors Program WASHINGTON, June 2 /PRNewswire-FirstCall/ -- IBM (NYSE: IBM ) today announced it was selected for its contributions to the EuResist research project for AIDS treatment as a Computerworld Honors Progra...

IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant

CMV is the most serious viral infection affecting transplant patients BOSTON, June 1 /PRNewswire/ -- New Phase III study results presented for the first time today at the ninth annual American Transplant Congress 2009 (ATC) demonstrate that doubling the duration of preventive therapy ('prop...

Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results

- Lead Investigator Professor John F. Thompson Presented Results at The Sixth International Symposium on Melanoma and Other Cutaneous Malignancies in New York City - - Detailed Efficacy Data to be Presented at ASCO May 29-June 2, 2009 - KNOXVILLE, Tenn., March 16 /PRNewswire-FirstCall/...

Building a New and Better Ankle

Improvements in Design Help Strengthen Total Ankle Replacements ROSEMONT, Ill., Sept. 2 /PRNewswire-USNewswire/ -- Some form of total ankle replacements (TAR), have been available to patients in the United States since first arriving in the marketplace more than 30 years ago. These implant...

Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention

PHILADELPHIA, July 29 /PRNewswire-USNewswire/ -- Bladder problems may leave a mark on the brain, by changing patterns of brain activity, possibly contributing to disrupted sleep and problems with attention. For one in six Americans who have overactive bladder, the involuntary bladder contracti...

Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day

- Focalin XR demonstrated better symptom control versus Concerta from 30 minutes to six hours post-dose in primary and secondary endpoints - Only Focalin XR provided onset of effect as early as 30 minutes post-dose - Additional analysis suggests Focalin XR provides comparable efficacy to ...

Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents

HONG KONG, July 7 /PRNewswire/ -- OrbusNeich today announced that data presented recently at the 17th Annual Meeting of the Japanese Society of Interventional Cardiology demonstrate that the Genous Bio-engineered R stent has better outcomes when compared to drug-eluting stents. Presented by ...

Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability

SAN FRANCISCO, June 9 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced new Phase I data for the company's diabetes mellitus program at the American Dia...

Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)

Study Suggests that Adding Singulair to Advair Offers no Additional Improvement in Overall Asthma Control RESEARCH TRIANGLE PARK, N.C. and TORONTO, May 18 /PRNewswire-FirstCall/ -- Patients with both asthma and allergic rhinitis, or seasonal allergies, experience significantl...

Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent

SPIRIT III Results Demonstrate Superior Reduction in In-Segment Late Loss, Non-Inferiority in Target Vessel Failure and Low Rates of MACE with XIENCE V Compared to TAXUS ABBOTT PARK, Ill., April 22 /PRNewswire-FirstCall/ -- A study published in today's Journal of the A...

In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy

PHILADELPHIA, April 15 /PRNewswire-USNewswire/ -- Before gene therapy becomes practical for treating human diseases, researchers must master the details of safe and effective delivery. Cardiology researchers at The Children's Hospital of Philadelphia have advanced delivery techniques by cre...

Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinson's Disease

Effort utilizes Phreesia's automated patient check-in system to enable better management of medication wear-off NEW YORK, April 15 /PRNewswire/ -- Phreesia, Inc., the Patient Check-In Company, has announced that it will integrate a new screening tool developed by researchers at...

Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids

- Glucocorticoids, commonly known as steroids, widely used to treat inflammatory conditions but can increase the risk of osteoporotic fractures with up to 50% of patients on long-term therapy at risk(1,2) - Study of more than 800 men and women shows higher bone mineral density with Rec...

Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation

BOSTON, April 10 /PRNewswire/ -- Data from experimental work on the use of organs from cardiac arrested donors will be presented this week at the International Society for Heart and Lung Transplantation's 28th Annual Meeting and Scientific Sessions. Utilizing donors after cardiac death (DCD), ...

Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine

NEW YORK, Feb. 4 /PRNewswire/ -- There is a large and growing "treatment gap" between the number of patients worldwide who would benefit from an organ transplant and the number of organs available, a gap that is impacting transplant medicine markets, according to a new market research report f...

First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs

HWI Scientist Dr. Dan Gewirth's Groundbreaking Research Makes Cover of Molecular Cell BUFFALO, N.Y., Oct. 19 /PRNewswire/ -- Dr. Dan Gewirth, Hauptman-Woodward senior research scientist, has just solved the structure of the first mammalian GRP94 protein implicated ...

Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics' Hypertension Better Controlled With Equal Access to Care

DALLAS, Sept. 12 /PRNewswire/ -- With equal access to medical care and medication, Hispanic men and women have as good or greater chance as non- Hispanics of controlling their high blood pressure. When researchers studied blood pressure control in Hispanics as part of the ALLHAT (Antihypertens...

Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span

MELBOURNE, Australia, March 23, 2007 /PRNewswire/ -- Scientists at WEHI have made a discovery with potentially profound implications for the care of patients, especially those undergoing cancer chemotherapy. The research team led by Drs Benjamin Kile and David Huang has discovered that platelet ...

Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease

BARCELONA, Spain, May 22, 2007 /PRNewswire/ -- A three-year follow-up subset analysis presented today as a late-breaking clinical trial at EuroPCR 2007 showed that the CYPHER(R) Sirolimus-eluting Coronary Stent had results comparable to coronary artery bypass grafting (CABG or bypass surge...

New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings

Registry Analysis Published in Journal Heart Finds Taxus Stent, Implantation of Multiple Stents and Small Vessel Size To Be Independent Predictors of Need for Another Procedure MIAMI LAKES, Fla., June 4, 2007 /PRNewswire via COMTEX News Network/ -- An analysis of data from the Western Denmark ...

Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study

COPENHAGEN, June 21, 2007-Novo Nordisk today announced clinical results from the first of five phase 3 studies with liraglutide - the once-daily human GLP-1 analogue. The 26-week study is part of the LEAD(TM) (Liraglutide Effect and Action in Diabetes) programme and included 581 patients with type...

Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients

PHILADELPHIA, July 3, 2007-- – The appearance of a rash in cancer patients treated with erlotinib (Tarceva) is strongly associated with longer survival, according to researchers from the drug’s developer, OSI Pharmaceuticals, Inc. This is not the first time that rash has been associate...

The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem Cells Work Better

Stem Cells Isolated from Females Regenerate Skeletal Muscle More Efficiently than Male Cells PITTSBURGH, April 09, 2007 /PRNewswire/ -- Female stem cells derived from muscle have a greater ability to regenerate skeletal muscle tissue than male cells, according to a study at Children's Hospital of ...

New Advances in Gastric Diagnostics: Smaller is Better

In recent years, miniaturization has opened up exciting possibilities in the area of gastric diagnostics. New technology may make routine GI diagnostic procedures as simple as swallowing a vitamin pill-sized encapsulated unit in the not-too-far future, and the present reality is that these units a...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...supplementary information and are not a substitute for financial measures calculated in accordance with GAAP. Isis reports these pro forma results to better enable financial statement users to assess and compare its historical performance and project its future operating results and cash flows. Further, t...

Study Shows Brain Fitness can Save Medicare Billions

...icipants who did just ten hours of special computerized brain exercises had better health outcomes, lowering projected Medicare costs by hundreds of dollars p... $128 on an unadjusted basis.) "This data indicates that we can have better health outcomes at significantly lower costs," said Henry Mahncke, PhD, vic...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

...in the 45U/kg dose was also clinically important, and a trend in liver volume reduction was observed. The 60U/kg dose performed numerically as well or better than 45U/kg across all measured clinical endpoints. The specific data from this trial will be presented at a scientific meeting later this year...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

...iling versus clipping following sound evidence that demonstrates that if an aneurysm is suitable for either treatment, that coiling is associated with better results). An analysis of study results showed that with neurosurgical clipping (traditional surgery that requires opening the skull) for aneurysmal su...

S.C. Medical Home Pilot for Diabetes Enrolls 1,110

...al societies." "The goal is to reduce the disconnects in health care, improve quality of life for the patient, create tighter relationships and better communications, and add for the first time a focus on measurement of quality and continuous improvement of clinical outcomes. We're pleased to work wi...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

...rology, metabolism, parasitology, growth and development and cancer. Along with his colleagues, Dr. Jacob's team hopes to use knockout rats to gain a better understanding of disease processes related to hypertension, heart disease, kidney failure and cancer. ZFNs are engineered proteins that induc...

Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)

... the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior phar...ogy, neurology and other conditions. Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior phar...

Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

... About Artefill: Artefill is the first and only FDA-approved microsphere-enhanced collagen filler for the correction of nasolabial folds, better known as smile lines. The safety and effectiveness of Artefill has been extensively studied over the past eight years. Since Artefill was approved in ...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

...nt R&D, Danone Research. "We hope the two young investigators will advance our knowledge in the growing field of probiotics and provide insight to better understanding the full potential of 'friendly' microorganisms and the mechanisms in which they promote human health." "We are very pleased w...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

...tudy's authors. "Our findings confirmed initial assumptions that the low stiffness properties of this porous metal --similar to cancellous bone--were better able to transfer physiological stresses, theoretically decreasing the detrimental effects of stress-shielding commonly seen around traditional acetabu...

International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit

... are hopeful that with this new imaging technology, more selective pain management approaches with fewer side effects can be instituted resulting in a better quality of life." Finally, the report supports the identification of taconite, which has not yet been categorized as asbestos but causes a d...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

...ng research-based pharmaceutical and healthcare companies, and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit GlaxoSmithKline on the World Wide Web at www.gsk.com . About Human Genome Sciences ...

Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease

...rebrovascular conditions, and neuromuscular disorders. Barrow's clinicians and researchers are devoted to providing excellent patient care and finding better ways to treat neurological disorders. About Sun Health Research Institute For 23 years, Sun Health Research Institute, part of nonprofit ...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

...ess for them to be truly effective. For that to happen, we need to get much better at early detection and diagnosis of Alzheimer's. Phase III Alzhe...ticipants for clinical studies is the second greatest barrier to developing better treatments for Alzheimer's disease, behind inadequate funding. The Alzheime...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

...arly 100% of cervical cancers. A decade ago, the first test for HPV DNA, the HC2 test, was approved by the FDA to be used along with the Pap smear to better identify patients at risk for cervical cancer. Today, more than 10 million HPV DNA tests are conducted annually, and the total number of HPV DNA test...

Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris

...abling company that develops pharmacogenomic (PGx) diagnostics that lead to better patient outcomes through personalized medicine. Sirius generates value by i...es, leading to proprietary and commercially viable PGx products that enable better drug treatment. The Company's first product is a genetic predictor of respo...